UnitedHealth Group Incorporated (UNH) — closed signal from April 10, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on July 9, 2026 — +38.2% at the close.
Predicted vs. what happened
What happened
Reached its target in 11 days.
The thesis — published April 10, 2026
UnitedHealth is worth cautious interest short-term. A Medicare Advantage payment update made future reimbursements clearer and prompted analysts to raise targets, creating a concrete policy-driven reason to watch the stock. The rally after the news looks stretched and the company faces weaker fundamentals than peers, so a calmer pullback would make the opportunity clearer.
Primary drivers
- Medicare Advantage rate relief makes future payments clearer
- Analyst target increases create a clearer recovery story after big losses
- Low price swings make the stock more defensive in uncertain markets
- Ongoing medical cost and regulation worries limit confidence
How it played out
UNH: target reached in 11 days
Lyra published a cautious short-term thesis for 10% growth from $308.07, with a $336.95 target. The thesis pointed to clearer Medicare Advantage payments, analyst target increases, low price swings, and continuing concerns about medical costs and regulation. It favored a calmer entry between $293.64 and $301.55 after the rally.
The stock reached the target in 11 days. It later peaked at $430.77 on July 8, a 39.8% gain within the window. UNH ended the period at $425.60, still above the target. The thesis played out fully.
What happened during the window
On April 21, UnitedHealth Group reported first-quarter revenue of $111.7 billion and raised its full-year adjusted earnings outlook to more than $18.25 per share. On May 5, UnitedHealthcare announced that it was eliminating authorization requirements for 30% of services that previously required insurer approval.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.